Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model

BACKGROUND: US FDA draft guidance includes pathogen reduction (PR) or secondary rapid bacterial testing (RT) in its recommendations for mitigating risk of platelet component (PC) bacterial contamination. An interactive budget impact model was created for hospitals to use when considering these techn...

Descripción completa

Detalles Bibliográficos
Autores principales: Prioli, Katherine M., Karp, Julie Katz, Lyons, Nina M., Chrebtow, Vera, Herman, Jay H., Pizzi, Laura T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244623/
https://www.ncbi.nlm.nih.gov/pubmed/30062464
http://dx.doi.org/10.1007/s40258-018-0409-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244623/
https://www.ncbi.nlm.nih.gov/pubmed/30062464
http://dx.doi.org/10.1007/s40258-018-0409-3

Ejemplares similares